Join our email list to stay up to date on the latest Amyloidosis news.

A groundbreaking study in ATTR amyloidosis, using novel CRISPR/Cas9, has dosed the first patient in the UK. This revolutionary technology brings us a step closer to the dream of curing inherited diseases like hereditary amyloidosis. (more…)

*

*

*

*